GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 348 filers reported holding GUARDANT HEALTH INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $366,865 | +37.7% | 10,530 | +46.9% | 0.00% | – |
Q2 2023 | $266,397 | -91.3% | 7,167 | -86.8% | 0.00% | -100.0% |
Q3 2022 | $3,061,000 | -2.7% | 54,342 | -22.7% | 0.00% | 0.0% |
Q2 2022 | $3,145,000 | +692.2% | 70,297 | +1087.0% | 0.00% | – |
Q1 2022 | $397,000 | -93.3% | 5,922 | -89.9% | 0.00% | -100.0% |
Q4 2021 | $5,957,000 | -54.3% | 58,725 | -45.3% | 0.00% | -50.0% |
Q3 2021 | $13,044,000 | -12.6% | 107,270 | -8.0% | 0.01% | -14.3% |
Q2 2021 | $14,919,000 | +110.1% | 116,552 | +161.8% | 0.01% | +40.0% |
Q1 2021 | $7,102,000 | +1124.5% | 44,519 | +1086.5% | 0.01% | – |
Q4 2020 | $580,000 | +42.9% | 3,752 | +1.4% | 0.00% | – |
Q3 2020 | $406,000 | +28.9% | 3,701 | +2.9% | 0.00% | – |
Q2 2020 | $315,000 | -28.7% | 3,595 | -47.0% | 0.00% | -100.0% |
Q1 2020 | $442,000 | +3.3% | 6,788 | +23.9% | 0.00% | – |
Q4 2019 | $428,000 | +10.3% | 5,480 | -10.0% | 0.00% | – |
Q3 2019 | $388,000 | +29.8% | 6,086 | +76.0% | 0.00% | – |
Q2 2019 | $299,000 | – | 3,457 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |